Amylyx Pharmaceuticals Market Sentiment

Amylyx Pharmaceuticals Inc

AMLXNASDAQ

Trade with Public

$28.04

0.260.94%

Ult. Agg.: Oct 6, 4:00 PM

$28.04

0.260.94%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Amylyx Pharmaceuticals Market Sentiment - Benzinga

Amylyx Pharmaceuticals Market Sentiment

Market sentiment signals for Amylyx Pharmaceuticals (AMLX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 15.8% short float

Options Flow▲ 0.73 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

13 analysts

Options Flow (P/C)

0.73

More calls — Bullish

11 calls · 8 puts

Avg Consensus PT

$28

-0.7%

Highest Price Target

$57

+103.3%

Guggenheim

Lowest Price Target

-85.7%

Goldman Sachs

Short Interest

15.8%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 27, 2026	Guggenheim	Seamus Fernandez—	+103.3%	$55 → $57	Maintained	Buy
Aug 19, 2026	Mizuho	Graig Suvannavejh—	+49.8%	$30 → $42	Maintained	Outperform
Aug 19, 2026	Guggenheim	Seamus Fernandez—	+96.1%	$40 → $55	Maintained	Buy
Aug 19, 2026	Baird	Joel Beatty—	+85.4%	$28 → $52	Maintained	Outperform
Aug 18, 2026	HC Wainwright & Co.	Andrew S. Fein—	+96.1%	$34 → $55	Maintained	Buy
Aug 17, 2026	Mizuho	Graig Suvannavejh—	+7.0%	$24 → $30	Maintained	Outperform
Aug 3, 2026	Citigroup	Geoff Meacham—	-7.3%	$20 → $26	Maintained	Buy
Jul 20, 2026	Mizuho	Graig Suvannavejh—	-14.4%	$21 → $24	Maintained	Outperform
Jun 25, 2026	Guggenheim	Seamus Fernandez—	+42.7%	$30 → $40	Maintained	Buy
Apr 28, 2026	Mizuho	Graig Suvannavejh—	-25.1%	$19 → $21	Maintained	Outperform
Mar 25, 2026	HC Wainwright & Co.	Andrew S. Fein—	+21.3%	$34 → $34	Maintained	Buy
Mar 19, 2026	Guggenheim	Seamus Fernandez—	+7.0%	$25 → $30	Maintained	Buy
Mar 4, 2026	HC Wainwright & Co.	Andrew S. Fein—	+21.3%	$28 → $34	Maintained	Buy
Mar 3, 2026	Stifel	James Condulis—	-25.1%	$21	Initiate	Buy
Feb 20, 2026	B of A Securities	Geoff Meacham—	-32.2%	$15 → $19	Maintained	Buy
Feb 10, 2026	HC Wainwright & Co.	Andrew S. Fein—	-0.1%	$20 → $28	Maintained	Buy
Nov 7, 2025	HC Wainwright & Co.	Andrew Fein—	-28.7%	$16 → $20	Maintained	Buy
Oct 17, 2025	Citigroup	Geoff Meacham—	-28.7%	$12 → $20	Maintained	Buy
Oct 16, 2025	Baird	Joel Beatty—	-32.2%	$10 → $19	Maintained	Outperform
Oct 3, 2025	B of A Securities	Geoff Meacham—	-42.9%	$14 → $16	Maintained	Buy
Sep 16, 2025	Goldman Sachs	Corinne Johnson—	-28.7%	$10 → $20	Maintained	Buy
Sep 15, 2025	Guggenheim	Seamus Fernandez—	-10.8%	$17 → $25	Maintained	Buy
Aug 28, 2025	B of A Securities	Geoff Meacham—	-50.1%	$10 → $14	Maintained	Buy
Jul 10, 2025	Goldman Sachs	Corinne Johnson—	-64.3%	$10	Reinstates	Buy
Jun 24, 2025	Guggenheim	Seamus Fernandez—	-39.4%	$17	Initiate	Buy